Aronson WJ - Search Results

1

Is body composition linked to prostate cancer survival?

Csizmadi I, Aronson WJ. Csizmadi I, et al. Among authors: aronson wj. Nat Rev Urol. 2021 Mar;18(3):135-136. doi: 10.1038/s41585-021-00427-7. Nat Rev Urol. 2021. PMID: 33442050 No abstract available.

2

Nutrition and prostate cancer.

Yip I, Heber D, Aronson W. Yip I, et al. Urol Clin North Am. 1999 May;26(2):403-11, x. doi: 10.1016/s0094-0143(05)70079-3. Urol Clin North Am. 1999. PMID: 10361562 Review.

3

Clinical characteristics in black and white men with prostate cancer in an equal access medical center.

Freedland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. Urology. 2000 Mar;55(3):387-90. doi: 10.1016/s0090-4295(99)00461-6. Urology. 2000. PMID: 10699616

4

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. Urology. 2000 Jul;56(1):87-91. doi: 10.1016/s0090-4295(00)00587-2. Urology. 2000. PMID: 10869631

5

Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy.

Freedland SJ, Dorey F, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. Urology. 2001 Mar;57(3):476-80. doi: 10.1016/s0090-4295(00)01016-5. Urology. 2001. PMID: 11248623

6

Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer.

Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. Aronson WJ, et al. Urology. 2001 Aug;58(2):283-8. doi: 10.1016/s0090-4295(01)01116-5. Urology. 2001. PMID: 11489728 Clinical Trial.

7

Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth.

Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Tymchuk CN, et al. Among authors: aronson wj. J Urol. 2001 Sep;166(3):1185-9. J Urol. 2001. PMID: 11490320

8

Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.

Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. J Urol. 2002 Feb;167(2 Pt 1):516-20. doi: 10.1016/S0022-5347(01)69076-1. J Urol. 2002. PMID: 11792909

9

Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.

Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. J Urol. 2002 Jul;168(1):110-5. J Urol. 2002. PMID: 12050502

10

Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy.

Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Freedland SJ, et al. Among authors: aronson wj. Urology. 2002 Jul;60(1):84-8. doi: 10.1016/s0090-4295(02)01660-6. Urology. 2002. PMID: 12100929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page